BridgeBio Oncology Therapeutics, Inc. (BBOT): 424B3 filed Jun 22, 2026

Name: BridgeBio Oncology Therapeutics, Inc. 424B3 (0001193125-26-277572)
Creator: BridgeBio Oncology Therapeutics, Inc.
Published: 2026-06-22

Form type: 424B3
Filing date: Jun 22, 2026
Accession number: 0001193125-26-277572
Filer: BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)